{
  "disease_name": "Hemolytic anemia due to red cell pyruvate kinase deficiency",
  "orpha_code": "766",
  "drugs": [
    {
      "name": "Pyrukynd",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/635841?name=766&mode=orpha&region=",
      "regulatory_id": "635841",
      "orpha_substance_code": "ORPHA:766",
      "details": [
        "Pyrukynd(Tradename                        - 09/11/2022)Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "Pyrukynd(Tradename                        - 09/11/2022)",
        "(Tradename                        - 09/11/2022)",
        "Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/623132?name=766&mode=orpha&region=&status=all",
          "text": "Pyrukynd",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/766",
          "text": "ORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/635841?name=766&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene",
      "substance_url": "/en/drug/substance/628215?name=766&mode=orpha&region=&status=all",
      "substance_id": "628215",
      "regulatory_url": "/en/drug/regulatory/628216?name=766&mode=orpha&region=",
      "regulatory_id": "628216",
      "orpha_substance_code": "ORPHA:766",
      "details": [
        "Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene(Medicinal product                        - 24/02/2022)Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene(Medicinal product                        - 24/02/2022)",
        "(Medicinal product                        - 24/02/2022)",
        "Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/628215?name=766&mode=orpha&region=&status=all",
          "text": "Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/766",
          "text": "ORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/628216?name=766&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Mitapivat sulfate",
      "substance_url": "/en/drug/substance/504971?name=766&mode=orpha&region=&status=all",
      "substance_id": "504971",
      "regulatory_url": "/en/drug/regulatory/590144?name=766&mode=orpha&region=",
      "regulatory_id": "590144",
      "orpha_substance_code": "ORPHA:766",
      "details": [
        "Mitapivat sulfate(Medicinal product                        - 22/04/2020)Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "Mitapivat sulfate(Medicinal product                        - 22/04/2020)",
        "(Medicinal product                        - 22/04/2020)",
        "Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/504971?name=766&mode=orpha&region=&status=all",
          "text": "Mitapivat sulfate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/766",
          "text": "ORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/590144?name=766&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Lentiviral vector containing the human liver and erythroid pyruvate kinase (PKLR) gene",
      "substance_url": "/en/drug/substance/406532?name=766&mode=orpha&region=&status=all",
      "substance_id": "406532",
      "regulatory_url": "/en/drug/regulatory/412031?name=766&mode=orpha&region=",
      "regulatory_id": "412031",
      "orpha_substance_code": "ORPHA:766",
      "details": [
        "Lentiviral vector containing the human liver and erythroid pyruvate kinase (PKLR) gene(Medicinal product                        - 22/08/2014)Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "Lentiviral vector containing the human liver and erythroid pyruvate kinase (PKLR) gene(Medicinal product                        - 22/08/2014)",
        "(Medicinal product                        - 22/08/2014)",
        "Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/406532?name=766&mode=orpha&region=&status=all",
          "text": "Lentiviral vector containing the human liver and erythroid pyruvate kinase (PKLR) gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/766",
          "text": "ORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/412031?name=766&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Pyrukynd",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/623133?name=766&mode=orpha&region=",
      "regulatory_id": "623133",
      "orpha_substance_code": "ORPHA:766",
      "details": [
        "Pyrukynd(Tradename                        - 17/02/2022)Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "Pyrukynd(Tradename                        - 17/02/2022)",
        "(Tradename                        - 17/02/2022)",
        "Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/623132?name=766&mode=orpha&region=&status=all",
          "text": "Pyrukynd",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/766",
          "text": "ORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/623133?name=766&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene",
      "substance_url": "/en/drug/substance/628215?name=766&mode=orpha&region=&status=all",
      "substance_id": "628215",
      "regulatory_url": "/en/drug/regulatory/644818?name=766&mode=orpha&region=",
      "regulatory_id": "644818",
      "orpha_substance_code": "ORPHA:766",
      "details": [
        "Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene(Medicinal product                        - 07/03/2023)Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene(Medicinal product                        - 07/03/2023)",
        "(Medicinal product                        - 07/03/2023)",
        "Disease(s) concernedORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/628215?name=766&mode=orpha&region=&status=all",
          "text": "Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/766",
          "text": "ORPHA:766 Hemolytic anemia due to red cell pyruvate kinase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/644818?name=766&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:03:32.491636",
  "run_number": 1,
  "total_drugs_found": 6,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Hemolytic+anemia+due+to+red+cell+pyruvate+kinase+deficiency&orphaCode=766&name=766&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Hemolytic anemia due to red cell pyruvate kinase deficiency",
    "orphaCode": "766",
    "name": "766",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}